Overview Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Status: RECRUITING Trial end date: 2026-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.Phase: PHASE2 Details Lead Sponsor: Biohaven Therapeutics Ltd.